Clinical Trial Update: A Single-Center, Double-Masked Evaluation of the Efficacy and Safety of PRX-100 in the Treatment of Early to Moderate Presbyopia [Phase 2]

View source ↗

Summary

Phase 2 clinical trial assessing PRX-100 for presbyopia has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Presbyopia

Drugs mentioned

• PRX-100 (PRX-100)

Snippet

Sponsor: LENZ Therapeutics, Inc | Conditions: Presbyopia | Phase 2 | Status: COMPLETED | Results posted: 2021-04-19